Evidence map›Paper›PMID 30858582›Full record

ReviewNature reviews. Nephrology2019

Glycosylation in health and disease.

Colin Reily, Tyler J Stewart, Matthew B Renfrow, Jan Novak

Erratum issuedOpen access · bronzeAbstract readReview
In one paragraph

Review in Nature reviews. Nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1,090 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,090citing papers in PubMed, 1 pooled it
70.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,090 citing papers in PubMed, 1 synthesis or guideline pooled it, 2,056 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Site-specific O-glycans influence lacritin structure and multimerization in tears.Protein science : a publication of the Protein Society · 2026
    Article
  5. Article
  6. Encoding Cell-Surface Receptor Function Through Glycosylation: Lessons From CD44.Chembiochem : a European journal of chemical biology · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Unraveling the Glycosylation Machinery ofInternational journal of molecular sciences · 2026
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

1,030 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Colin ReilyDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Tyler J StewartDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Matthew B RenfrowDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL, USA. renfrow@uab.edu.
Jan NovakDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA. jannovak@uab.edu.ORCID http://orcid.org/0000-0002-9211-6670
University of Alabama at Birmingham · USNational Institutes of Health · US

Funding

UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGARWAL, ANUPAM · 2008 to 2022
$18.3M
Elucidating IgA Nephropathy through Genetic Studies of IgA1 GlycosylationR01DK082753 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GHARAVI, ALI G, NOVAK, JAN · 2009 to 2024
$8.7M
Molecular Basis of Pathogenicity of IgA1-containing Immune ComplexesR01DK078244 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JAN NOVAK · 2007 to 2026
$6.0M
Genetics of IgA nephropathy by integrative network-based association studiesR01DK105124 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Krzysztof Kiryluk · 2015 to 2026
$4.8M
Analytical tools for the analysis of clustered O-glycans in clinical samplesR01GM098539 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RENFROW, MATTHEW B · 2011 to 2019
$2.7M
Abnormal STAT3 Signaling and Aberrant O-Glycosylation of IgA1 in IgA NephropathyK01DK106341 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI REILY, COLIN ROBERT · 2015 to 2021
$918k
Abnormal cytokine response and autoantigen production in IgA-producing subpopulations in IgA nephropathyR03DK122194 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI REILY, COLIN ROBERT · 2019 to 2020
$223k
Molecular Basis of Pathogenicity of IgA1-containing Immune ComplexesR56DK078244 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NOVAK, JAN · 2012 to 2012
$92k
IgA nephropathy and the role of clustered glycosylation initiation by GalNAc-transferasesF31DK109599 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STEWART, TYLER J · 2016 to 2017
$68k
NIDDK NIH HHS F31 DK109599NIDDK NIH HHS K01 DK106341NIDDK NIH HHS P30 DK079337NIDDK NIH HHS R01 DK078244NIDDK NIH HHS R01 DK082753NIDDK NIH HHS R01 DK105124NIDDK NIH HHS R03 DK122194NIDDK NIH HHS R56 DK078244NIGMS NIH HHS R01 GM098539
6 · The paper itself

Abstract

The glycome describes the complete repertoire of glycoconjugates composed of carbohydrate chains, or glycans, that are covalently linked to lipid or protein molecules. Glycoconjugates are formed through a process called glycosylation and can differ in their glycan sequences, the connections between them and their length. Glycoconjugate synthesis is a dynamic process that depends on the local milieu of enzymes, sugar precursors and organelle structures as well as the cell types involved and cellular signals. Studies of rare genetic disorders that affect glycosylation first highlighted the biological importance of the glycome, and technological advances have improved our understanding of its heterogeneity and complexity. Researchers can now routinely assess how the secreted and cell-surface glycomes reflect overall cellular status in health and disease. In fact, changes in glycosylation can modulate inflammatory responses, enable viral immune escape, promote cancer cell metastasis or regulate apoptosis; the composition of the glycome also affects kidney function in health and disease. New insights into the structure and function of the glycome can now be applied to therapy development and could improve our ability to fine-tune immunological responses and inflammation, optimize the performance of therapeutic antibodies and boost immune responses to cancer. These examples illustrate the potential of the emerging field of 'glycomedicine'.

Indexed as

GlycomicsGlycosylationApoptosisCongenital Disorders of GlycosylationGalectinsGlycoconjugatesHumansImmune EvasionImmunoglobulinsInflammationLeukocyte Common AntigensLeukosialinNeoplasm MetastasisNeoplasmsPolysaccharidesSelectinsGalectinsGlycoconjugatesImmunoglobulinsLeukocyte Common AntigensLeukosialinPolysaccharidesSelectinsSialic Acid Binding Immunoglobulin-like Lectins

Identifiers

PMID30858582
PMCPMC6590709
OpenAlexW2921437380

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.